Hematology Clinical Research Training Program

描述（由申请人提供）：宾夕法尼亚大学血液学临床研究培训计划成立于1978年，为132名男性和女性提供了培训。该计划的主要目标是帮助不同群体的个人为血液学和血液疾病的广泛定义学科的调查人员做好职业准备。教员包括37名各级教员，并制定了适当增减教员的计划。每年招收博士后8人，博士4人。候选人最初主要是从医学和儿科部门参加临床血液学培训项目的医生中抽取的。自1998年以来，我们还支持非医生的博士后学员，自2004年以来，支持博士预科学员，其中大多数是宾夕法尼亚大学的医学博士项目。与医学博士项目的联系利用了PI作为该项目主任的角色。博士前学生的加入反映了我们对长期价值的信念，即让有才华的学生参与血液学相关的研究，在他们的早期训练中

DESCRIPTION (provided by applicant): The Hematology Clinical Research Training Program at the University of Pennsylvania was established in 1978 and has provided training for 132 men and women. The program's primary goal is to help a diverse group of individuals prepare for careers as investigators in the broadly-defined discipline of hematology and blood disorders. The faculty includes 37 trainers of all academic ranks and a plan is in place for adding or withdrawing trainers when appropriate. Up to 12 new trainees are accepted each year (8 postdocs and 4 predocs). Candidates were originally were drawn primarily from physicians enrolled in the clinical hematology training programs in the Departments of Medicine and Pediatrics. Since 1998 we have also supported postdoctoral trainees who are not physicians and, since 2004, predoctoral trainees, most of whom are in Penn's MD-PhD program. The connection to the MD-PhD program takes advantage of the PI's role as the director of that program. The inclusion of predoctoral students reflects our belief in the long term value of involving talented students to hematology-related research at an earlier point in their training as scientists and physician-scientists. Essential features of the program include formal and informal advising, skills workshops, attendance at local seminars and national conferences, coursework, training in the responsible conduct of research, and an annual symposium. MD postdoctoral fellows have the option of enrolling in a Biomedical Graduate Studies (BGS) PhD program. Outcomes. 117 postdoctoral trainees (68 MD, 17 MD-PhD and 32 PhD) and 15 pre-doctoral trainees (10 MD-PhD and 5 PhD) have been supported. Of the 109 who have completed all stages of training, 56 (50%) hold full-time appointments at an academic institution, 13 (12%) are employed in industry, 1 (1%) works at the FDA, and 3 (3%) run transfusion services at the NIH or Red Cross (total 67%), all of which we consider appropriate outcomes. Of those who currently hold fulltime academic appointments, at least 68% currently hold or have had NIH research funding. A detailed plan for attracting and training a diverse group of men and women, monitoring their progress benchmarked with an individualized development plan, and receiving feedback from trainees, alumni and faculty is included in the application.